Trv Gp III, LLC

10% owner at Jounce Therapeutics, Inc.; 10% owner at Global Blood Therapeutics, Inc.

Sold, on record
$68.2M
Dollars the filings state
Form 4 sales
2
Latest Nov 12, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Global Blood Therapeutics, Inc.Unusual
    Mar 2, 2017 2017

    Sold 2M shares at $25.54 ($52.2M)

    Trv Gp III, LLC, 10% owner

    Sold 93.3% of holdings ($56M position)146,208 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Jounce Therapeutics, Inc.Unusual
    Nov 12, 2021 +1716 days

    Sold 1.9M shares at $8.38 ($15.9M)

    Trv Gp III, LLC, 10% owner

    Sold 62.3% of holdings ($25.5M position)1.1M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Trv Gp III, LLC
Source
Nov 12, 2021Nov 16, 2021Jounce Therapeutics, Inc.10% ownerForm 4 sale1.9M$15.9M62.3%UnusualSEC
Mar 2, 2017Mar 6, 2017Global Blood Therapeutics, Inc.10% ownerForm 4 sale2M$52.2M93.3%UnusualSEC